News

The company has enrolled around 240 patients in the trial in US and Taiwan sites. The primary endpoint of the trial is the change in glycated hemoglobin A1c

The results from a placebo-controlled, randomised, multicenter Phase 3 study treatment with abiraterone acetate in conjunction with prednisone or prednisolone resulted in a 35.4% reduction in the risk

Tesamorelin is a growth hormone-releasing factor (GRF) analogue that induces growth hormone production and its anabolic properties have led Theratechnologies to pursue its development in muscle wasting in

AT-406 is an orally available small molecule helps in neutralizing major inhibitors of apoptosis and is anticipated to be effective in treating cancers in conjunction with anti-cancer therapies.

Buccolam is indicated for the treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents, from 3 months to less than 18 years of age. Buccal

The trial is aimed to investigate the safety, pharmacokinetics and tolerability of BAL30072 following multiple ascending intravenous infusions in healthy volunteers. BAL30072 demonstrated safety and tolerability profile in

Haloperidol Injection, USP is also indicated for the control of tics and vocal utterances of Tourette’s disorder. Sagent’s haloperidol injection will be offered in 5mg per ml single-dose

Following the acquisition, the joint ventures will be completely owned by Biogen and will be named as Biogen Idec Italia and Biogen Idec Switzerland. The joint venture collaboration

The Veeva CRM suite consists of VBioPharma, VMobile, and VInsights, iRep for closed loop marketing on the iPad. Veeva CRM improves user adoption and sales effectiveness, while reducing